Payments to Acquire Property, Plant, and Equipment of Lyra Therapeutics, Inc. from 31 Mar 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Lyra Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2019 to 31 Dec 2024.
  • Lyra Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2024 was $2,149,000, a 4676% increase year-over-year.
  • Lyra Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $2,338,000, a 123% increase from 2023.
  • Lyra Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1,047,000, a 538% increase from 2022.
  • Lyra Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $164,000, a 95% decline from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Lyra Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,338,000 +$1,291,000 +123% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 $1,047,000 +$883,000 +538% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 $164,000 -$3,221,000 -95% 01 Jan 2022 31 Dec 2022 10-K 22 Mar 2024 2023 FY
2021 $3,385,000 +$1,610,000 +91% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $1,775,000 +$1,564,000 +741% 01 Jan 2020 31 Dec 2020 10-K 09 Mar 2022 2021 FY
2019 $211,000 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY

Lyra Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $2,149,000 +$2,104,000 +4676% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $45,000 -$48,000 -52% 01 Jan 2023 31 Mar 2023 10-Q 30 Apr 2024 2024 Q1
Q1 2022 $93,000 -$1,067,000 -92% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q1 2021 $1,160,000 +$1,152,000 +14400% 01 Jan 2021 31 Mar 2021 10-Q/A 02 Nov 2022 2022 Q1
Q1 2020 $8,000 -$44,000 -85% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q1 2019 $52,000 01 Jan 2019 31 Mar 2019 10-Q 28 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.